Article
Cancer Vaccines: Recent Insights and Future Directions
19 Oct 2024
Abstract excerpt
The field of cancer immunotherapy has seen incredible advancements in the past decades. mRNA-based cancer vaccines generating de novo T cell responses, particularly against tumor-specific antigens (TSAs), have demonstrated promising clinical outcomes and overcome diverse challenges. Despite the high potential of neoantigens to provide personalized immunotherapies through their tumor specificity and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
